XSHG
601678
Market cap1.74bUSD
Oct 09, Last price
5.74CNY
1D
1.41%
1Q
5.51%
Jan 2017
2.32%
IPO
-10.17%
Name
Befar Group Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Befar Group Co.,Ltd operates as a Chinese enterprise, primarily engaged in the production and sale of caustic soda and propylene oxide. Its extensive chemical product range encompasses items such as propylene oxide, hydrochloric acid, hydrogen peroxide, trichloroethylene, epichlorohydrin, di-chloropropane solvents, propylene chloride, fluorochemicals, polyether products, sodium hypochlorite solution, and sodium sulfate decahydrate. Furthermore, Befar Group provides a suite of specialized auxiliary products, including various demulsifiers (water-soluble, oil-soluble, desalting for refinery, and inverse), polyoxyethylene non-ionic surfactants, general surfactants, drainage acids, acidizing corrosion inhibitors, and heavy oil viscosity reducers. The company's global reach extends to approximately 100 nations and territories, where it distributes its goods. Established in 1968, Befar Group Co.,Ltd maintains its corporate headquarters in Binzhou, China.
Key people
Yinghui Cai
Vice President · since 2022
Hui Gao
Vice President · since 2023
Hong'an Liu
Vice Chairman of the Board, Vice President · since 2024
Xusheng Qiao
Vice President · since 2024
Huiqing Sun
Vice President · since 2023
Fengjiu Xu
Vice President · since 2015
Zhenjun Yang
Vice President · since 2018
Shufang Sun
Chief Financial Officer, Secretary of the Board · since 2024
Hongbo Dong
President, Director · since 2024
Jiang Yu
Chairman of the Board · since 2021
Zhongzheng Zhang
Director · since 2007
Independent Director · since 2021
Haixia Li
Independent Director · since 2021
Qian Wang
Independent Director · since 2024
Headquarters & legal address
山东省滨州市黄河五路869号
滨州市, SD 100000
CN
滨州市, SD 100000
CN
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||